U.S. flag

An official website of the United States government

NM_022124.6(CDH23):c.5418C>G (p.Asp1806Glu) AND not specified

Germline classification:
Benign/Likely benign (4 submissions)
Last evaluated:
Dec 10, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000039211.18

Allele description [Variation Report for NM_022124.6(CDH23):c.5418C>G (p.Asp1806Glu)]

NM_022124.6(CDH23):c.5418C>G (p.Asp1806Glu)

Gene:
CDH23:cadherin related 23 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.1
Genomic location:
Preferred name:
NM_022124.6(CDH23):c.5418C>G (p.Asp1806Glu)
Other names:
p.D1806E:GAC>GAG
HGVS:
  • NC_000010.11:g.71784336C>G
  • NG_008835.1:g.392390C>G
  • NM_022124.6:c.5418C>GMANE SELECT
  • NP_071407.4:p.Asp1806Glu
  • NC_000010.10:g.73544093C>G
  • NM_001171932.1:c.*166856C>G
  • NM_022124.5:c.5418C>G
  • c.5418C>G
Protein change:
D1806E
Links:
dbSNP: rs74145660
NCBI 1000 Genomes Browser:
rs74145660
Molecular consequence:
  • NM_022124.6:c.5418C>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
50

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000062895Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(Mar 22, 2012)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV000167618GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(May 13, 2013)
germlineclinical testing

Citation Link,

SCV000230599Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Benign
(May 20, 2015)
germlineclinical testing

Citation Link,

SCV002051007Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Dec 10, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot provided5150not providednot providednot providedclinical testing

Citations

PubMed

Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%.

Roux AF, Faugère V, Le Guédard S, Pallares-Ruiz N, Vielle A, Chambert S, Marlin S, Hamel C, Gilbert B, Malcolm S, Claustres M; French Usher Syndrome Collaboration.

J Med Genet. 2006 Sep;43(9):763-8. Epub 2006 May 5.

PubMed [citation]
PMID:
16679490
PMCID:
PMC2564578

Distribution and frequencies of CDH23 mutations in Japanese patients with non-syndromic hearing loss.

Wagatsuma M, Kitoh R, Suzuki H, Fukuoka H, Takumi Y, Usami S.

Clin Genet. 2007 Oct;72(4):339-44.

PubMed [citation]
PMID:
17850630
See all PubMed Citations (3)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000062895.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided51not providednot providedclinical testing PubMed (3)

Description

Asp1806Glu in exon 42 of CDH23: This variant is not expected to have clinical si gnificance due to its occurrence at an equal frequency in cases compared to the general population (Roux 2006, Wagatsuma 2007) and is listed in dbSNP with 10/28 8 (3.5%) frequency (rs74145660).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided51not provided50not provided

From GeneDx, SCV000167618.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000230599.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002051007.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024